EMA Consults On Protecting Personal & Commercial Data In New Clinical Trial System

 
• By Vibha Sharma

The EMA explains how sponsors can comply with transparency requirements under the EU Clinical Trial Regulation while protecting personal data and commercially confidential information.

Closed up finger on keyboard with word CLINICAL TRIALS
The default setting in CTIS is to make data/documents public at the first opportunity • Source: Shutterstock

More from Clinical Trials

More from R&D